Clinical characteristics and treatment outcomes of primary autoimmune hemolytic anemia: A single center study from South India

Blood Research

Volumn 51, Issue 2, 2016, Pages 88-94

  Prabhu, Raghuveer ^a   Bhaskaran, Renjitha ^a   Shenoy, Veena ^a   Rema, G ^a   Sidharthan, Neeraj ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Autoimmune hemolytic anemia; Azathioprine; Cold agglutinin disease; Corticosteroids; Warm autoimmune hemolytic anemia

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HEMOGLOBIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB;

ABSCESS; ADULT; AGED; ANEMIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CEREBRAL SINUS THROMBOSIS; CLINICAL ARTICLE; COLD AGGLUTININ DISEASE; CORTICOSTEROID THERAPY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HUMAN; INDIA; LUNG EMBOLISM; MALE; PNEUMONIA; RETICULOCYTE COUNT; SEPSIS; SOFT TISSUE DISEASE; SPLENOMEGALY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN THROMBOSIS; WARM AUTOIMMUNE HEMOLYTIC ANEMIA;

EID: 84977574967     PISSN: 2287979X     EISSN: 22880011     Source Type: Journal    
DOI: 10.5045/br.2016.51.2.88     Document Type: Article

References (22)

1. Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood 2014;124:2930-6.
2. Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004.
3. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol 2002;69:258-71.
4. Barcellini W, Revelli N, Imperiali FG, et al. Comparison of traditional methods and mitogen-stimulated direct antiglobulin test for detection of anti-red blood cell autoimmunity. Int J Hematol 2010;91:762-9.
5. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica 2014;99:1547-54.
6. Berentsen S, Ulvestad E, Gjertsen BT, et al. Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 2004;103:2925-8.
7. Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood 2010;116:1831-8.
8. Crowther M, Chan YL, Garbett IK, Lim W, Vickers MA, Crowther MA. Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood 2011;118: 4036-40.
9. Berentsen S, Tjønnfjord GE. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev 2012;26:107-15.
10. Naithani R, Agrawal N, Mahapatra M, Pati H, Kumar R, Choudhary VP. Autoimmune hemolytic anemia in India: clinicohematological spectrum of 79 cases. Hematology 2006;11:73-6.
11. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood 1987;69:820-6.
12. Aladjidi N, Leverger G, Leblanc T, et al. New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica 2011;96:655-63.
13. Naithani R, Agrawal N, Mahapatra M, Kumar R, Pati HP, Choudhry VP. Autoimmune hemolytic anemia in children. Pediatr Hematol Oncol 2007;24:309-15.
14. Van De Loosdrecht AA, Hendriks DW, Blom NR, Smit JW, De Wolf JT, Vellenga E. Excessive apoptosis of bone marrow erythroblasts in a patient with autoimmune haemolytic anaemia with reticulocytopenia. Br J Haematol 2000;108:313-5.
15. Kamesaki T, Toyotsuji T, Kajii E. Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases. Am J Hematol 2013;88:93-6.
16. Dussadee K, Taka O, Thedsawad A, Wanachiwanawin W. Incidence and risk factors of relapses in idiopathic autoimmune hemolytic anemia. J Med Assoc Thai 2010;93(Suppl 1):S165-70.
17. Jaime-Pérez JC, Rodríguez-Martínez M, Gómez-de-León A, Tarín-Arzaga L, Gómez-Almaguer D. Current approaches for the treatment of autoimmune hemolytic anemia. Arch Immunol Ther Exp (Warsz) 2013;61:385-95.
18. O'Connell N, Goodyer M, Gleeson M, et al. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation. Pediatr Transplant 2014;18:E22-4.
19. Swiecicki PL, Hegerova LT, Gertz MA. Cold agglutinin disease. Blood 2013;122:1114-21.
20. Berentsen S, Randen U, Vågan AM, et al. High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. Blood 2010;116:3180-4.
21. Hoffman PC. Immune hemolytic anemia--selected topics. Hematology Am Soc Hematol Educ Program 2009:80-6.
22. Otaibi ZD, Rao R, Sadashiv SK. A case of evans syndrome: a clinical condition with under-recognized thrombotic risk. J Hematol 2015;4:205-9.